Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001199835-22-000822
Filing Date
2022-12-19
Accepted
2022-12-19 16:18:56
Documents
42
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 PEAK PHARMACEUTICALS, INC. 09/30/2020 10-K pkph093020-10k.htm 10-K 508494
2 CERTIFICATION pkph093020-ex31_1.htm EX-31.1 16700
3 CERTIFICATION pkph093020-ex31_2.htm EX-31.2 17315
4 CERTIFICATION pkph093020-ex32_1.htm EX-32.1 5525
5 CERTIFICATION pkph093020-ex32_2.htm EX-32.2 5652
  Complete submission text file 0001199835-22-000822.txt   1721106

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE pkph-20200930.xml EX-101.INS 165874
7 XBRL SCHEMA FILE pkph-20200930.xsd EX-101.SCH 20744
8 XBRL CALCULATION FILE pkph-20200930_cal.xml EX-101.CAL 23274
9 XBRL DEFINITION FILE pkph-20200930_def.xml EX-101.DEF 36580
10 XBRL LABEL FILE pkph-20200930_lab.xml EX-101.LAB 144597
11 XBRL PRESENTATION FILE pkph-20200930_pre.xml EX-101.PRE 111383
Mailing Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260
Business Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260 480.659.6404
PEAK PHARMACEUTICALS, INC. (Filer) CIK: 0001452804 (see all company filings)

EIN.: 261973257 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-53855 | Film No.: 221471305
SIC: 2834 Pharmaceutical Preparations